Shenyang Sunshine Pharmaceutical Co., Ltd.

This Phase 2 trial is testing two experimental drugs (SSGJ-705 and SSGJ-612) with or without chemotherapy in 150 adults with advanced HER2-positive solid tumors, including colorectal, bladder, breast, bile duct, and stomach cancers. The goal is to see if the combination can shrin…

This early-stage trial is testing a new biologic drug called SPGL008 in 96 adults with advanced solid tumors that have spread or cannot be removed. The main goals are to find a safe dose and check for side effects. The drug is given either through a vein or under the skin. This i…

This early-stage trial is testing a new drug called SSGJ-709 in 15 people with advanced cancers that have spread. The drug is designed to block two immune system brakes (PD-1 and LAG-3) at once, potentially helping the body fight tumors. The main goals are to check safety and how…

This study tests a new drug called SSGJ-706, either alone or with other treatments, for people with advanced non-small cell lung cancer (NSCLC) that has not been treated before. About 240 adults will take part to see if the drug shrinks tumors and how safe it is. The goal is to f…

This early-stage study tests a single dose of SSS55 injection in 26 healthy adults in China. The main goal is to check if it is safe and how the body handles it. Researchers will also look at how it affects the immune system. This is a first step before testing it in people with …